Mucosal Environment and HIV Prevention (MEHP II) (R01)

The summary for the Mucosal Environment and HIV Prevention (MEHP II) (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Mucosal Environment and HIV Prevention (MEHP II) (R01): The purpose of the Mucosal Environment and HIV Prevention II (MEHP II) Funding Opportunity Announcement (FOA) is to solicit applications that support innovative proof-of-concept/feasibility non-vaccine biomedical prevention (nBP) research needed to support and advance the development of safer and more effective microbicides and Pre-Exposure Prophylaxis (PrEP) strategies. The MEHP II will support innovative, high-risk, hypothesis-driven research that provides a better understanding of how prevention products/drug delivery strategies interact with the micro- and macro-environments of the male and female genital and gastrointestinal (GI) mucosa. This FOA is intended to support innovative biomedical research efforts, which may or may not involve active pharmaceutical ingredients (APIs), formulation/excipient and/or a device currently under development. This FOA is not intended to support the preclinical or clinical development of new nBP candidates or their delivery systems.
Federal Grant Title: Mucosal Environment and HIV Prevention (MEHP II) (R01)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-AI-14-036
Type of Funding: Grant
CFDA Numbers: 93.855, 93.856
CFDA Descriptions: Allergy, Immunology and Transplantation Research; Microbiology and Infectious Diseases Research
Current Application Deadline: Nov 21, 2014
Original Application Deadline: Nov 21, 2014
Posted Date: Jul 22, 2014
Creation Date: Jul 22, 2014
Archive Date: Dec 22, 2014
Total Program Funding: $1,200,000
Maximum Federal Grant Award: $1,200,000
Minimum Federal Grant Award: none
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
State governments
County governments
Private institutions of higher education
Independent school districts
Native American tribal governments (Federally recognized)
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
City or township governments
Special district governments
Additional Information on Eligibility
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-14-036.html
Grant Announcement Contact
NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants
Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical ...
Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial N...
Centers for Research in Emerging Infectious Diseases (CREID) Network Coordination Center (...
Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed)
Center of Excellence for Systems Modeling of Infection and Immunity across Biological Scal...
Center for HIV/AIDS Vaccine Immunology (CHAVI)
Genomics of Transplantation Cooperative Research Program
Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health
Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical ...
Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Mino...
Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowe...
NINDS Program Project Grant (P01 Clinical Trial Optional)
Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial N...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com